GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unjha Formulations Ltd (BOM:531762) » Definitions » EV-to-EBITDA

Unjha Formulations (BOM:531762) EV-to-EBITDA : 15.37 (As of Jun. 02, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Unjha Formulations EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Unjha Formulations's enterprise value is ₹97.6 Mil. Unjha Formulations's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹6.3 Mil. Therefore, Unjha Formulations's EV-to-EBITDA for today is 15.37.

The historical rank and industry rank for Unjha Formulations's EV-to-EBITDA or its related term are showing as below:

BOM:531762' s EV-to-EBITDA Range Over the Past 10 Years
Min: -100.23   Med: 10.65   Max: 79.64
Current: 15.37

During the past 13 years, the highest EV-to-EBITDA of Unjha Formulations was 79.64. The lowest was -100.23. And the median was 10.65.

BOM:531762's EV-to-EBITDA is ranked worse than
54.97% of 735 companies
in the Drug Manufacturers industry
Industry Median: 14.21 vs BOM:531762: 15.37

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-02), Unjha Formulations's stock price is ₹23.09. Unjha Formulations's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.910. Therefore, Unjha Formulations's PE Ratio (TTM) for today is 25.37.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Unjha Formulations EV-to-EBITDA Historical Data

The historical data trend for Unjha Formulations's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unjha Formulations EV-to-EBITDA Chart

Unjha Formulations Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.47 8.26 12.36 12.90 14.50

Unjha Formulations Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.90 10.84 9.72 14.26 14.50

Competitive Comparison of Unjha Formulations's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unjha Formulations's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Unjha Formulations's EV-to-EBITDA falls into.


;
;

Unjha Formulations EV-to-EBITDA Calculation

Unjha Formulations's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=97.554/6.348
=15.37

Unjha Formulations's current Enterprise Value is ₹97.6 Mil.
Unjha Formulations's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Unjha Formulations  (BOM:531762) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Unjha Formulations's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=23.09/0.910
=25.37

Unjha Formulations's share price for today is ₹23.09.
Unjha Formulations's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.910.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Unjha Formulations EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Unjha Formulations's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Unjha Formulations Business Description

Traded in Other Exchanges
N/A
Address
Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.

Unjha Formulations Headlines

No Headlines